What causes abnormal serum estrogen and progesterone levels in a woman using a Mirena levonorgestrel-releasing intrauterine device, and how should this be managed?

Abnormal Estrogen and Progesterone Levels on Mirena IUD

The Mirena (levonorgestrel-releasing IUD) does not cause "abnormal" estrogen and progesterone levels—it causes expected physiologic changes: estrogen levels remain normal (follicular phase range), while progesterone levels may be lower than typical luteal phase values due to variable ovulation suppression, though most women continue to ovulate.

Understanding the Hormonal Effects

The levonorgestrel released by Mirena acts primarily locally on the endometrium, with minimal systemic hormonal disruption:

Estrogen Levels

• Estrogen levels remain normal and similar to the follicular phase of regularly menstruating women 1
• The IUD does not suppress follicular development or estrogen production 2
• Women maintain physiologic estrogen levels throughout use

Progesterone Levels

• Progesterone levels are typically lower than in normal ovulatory cycles 3
• This occurs because:
  • After long-term use (6+ years), approximately 78.5% of women still ovulate 4
  • However, some women develop anovulatory cycles (14.3%) or luteal insufficiency 4
  • Even in ovulatory cycles, progesterone may be reduced compared to non-IUD users 3

Serum Levonorgestrel Levels

• Initial levels: 253-260 pg/mL in first 2 months 1, 5
• Decline over time: 137 pg/mL at 7 years, 119 pg/mL at 8.5 years 1
• Levels remain detectable and therapeutically effective even after extended use 4

Clinical Implications

What This Means for Management

No intervention is needed for these expected hormonal patterns unless the patient has specific symptoms or concerns:

1. If asymptomatic: Provide reassurance that these hormonal changes are normal and expected with Mirena use 6

2. If bleeding irregularities occur (the most common concern):

   • First-line: NSAIDs for 5-7 days 6
   • Reassure that bleeding patterns often improve over time
   • If unacceptable to patient, consider alternative contraceptive methods 6

3. If concerned about ovulation/fertility preservation:

   • Reassure that most women (>75%) continue to ovulate with long-term use 4
   • Fertility returns rapidly after removal

Important Caveats

• Body habitus matters: Higher BMI and weight correlate with lower serum levonorgestrel levels 1, though contraceptive efficacy remains intact
• Stress response: The LNG-IUD may potentiate cortisol reactivity to stress 7, which could be relevant in patients with mood concerns
• Not truly "abnormal": These are predictable pharmacologic effects, not pathologic findings

When to Investigate Further

Only pursue additional workup if 6:

• Pregnancy is suspected (late period >1 week)
• Signs of pelvic inflammatory disease
• New pathologic uterine conditions (polyps, fibroids)
• Thyroid disorders suspected
• Drug interactions present

The Bottom Line

Laboratory measurement of estrogen and progesterone levels in asymptomatic Mirena users is unnecessary and may cause unwarranted concern. The contraceptive mechanism relies primarily on local endometrial effects, not systemic ovulation suppression 4. The hormonal changes observed are expected physiologic responses to intrauterine levonorgestrel delivery and do not require treatment or device removal unless the patient experiences unacceptable symptoms.